Alyeska Investment Group’s VIVEVE MED INC VIVE Stock Holding History

Alyeska Investment Group’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,181	Closed	-$81.4K	–	509
2019 Q4	$103K	Buy	+8,181	New	+$233K	﹤0.01%	389
2018 Q3	–	Sell	-322	Closed	-$876K	–	542
2018 Q2	$876K	Sell	322 -581	-64%	-$1.67M	0.01%	404
2018 Q1	$3.31M	Buy	+903	New	+$3.93M	0.03%	318
2017 Q2	–	Sell	-250	Closed	-$1.58M	–	568
2017 Q1	$1.58M	Buy	+250	New	+$1.22M	0.01%	409

Other funds holding VIVE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JCM

Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return

Alyeska Investment Group's VIVE Position: Q1 2020 in Review

Alyeska Investment Group sold out of VIVEVE MED INC (VIVE) in Q1 2020, closing a stake of 8,181 shares — an estimated $81.4K sold.

Alyeska Investment Group first reported a position in VIVE in Q1 2017 and held it in 4 quarters. The position peaked at $3.31M in Q1 2018. 11 funds tracked by Wall St. Rank hold VIVE as of Q1 2020.

Alyeska Investment Group reported no remaining VIVEVE MED INC position as of Q1 2020 after selling out during the quarter.
Alyeska Investment Group sold 8,181 VIVEVE MED INC shares in Q1 2020, an estimated $81.4K.
Alyeska Investment Group first reported a position in VIVEVE MED INC in Q1 2017 and held it in 4 quarters.
Alyeska Investment Group's VIVEVE MED INC position peaked at $3.31M in Q1 2018.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2020.

Based on Alyeska Investment Group's 13F filing for Q1 2020, filed 15 May 2020.